Cargando…
Hedgehog Cholesterolysis: Specialized Gatekeeper to Oncogenic Signaling
Discussions of therapeutic suppression of hedgehog (Hh) signaling almost exclusively focus on receptor antagonism; however, hedgehog’s biosynthesis represents a unique and potentially targetable aspect of this oncogenic signaling pathway. Here, we review a key biosynthetic step called cholesterolysi...
Autores principales: | Callahan, Brian P., Wang, Chunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695875/ https://www.ncbi.nlm.nih.gov/pubmed/26473928 http://dx.doi.org/10.3390/cancers7040875 |
Ejemplares similares
-
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
por: Aberger, Fritz, et al.
Publicado: (2017) -
Hedgehog signaling and the glioma-associated oncogene in cancer radioresistance
por: Zhang, Li, et al.
Publicado: (2023) -
Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy
por: Pandolfi, Silvia, et al.
Publicado: (2015) -
Dentists with enhanced skills (Special Interest) in Endodontics: gatekeepers views in London
por: Ghotane, Swapnil G., et al.
Publicado: (2015) -
EGFR T790M: revealing the secrets of a gatekeeper
por: Ko, Brian, et al.
Publicado: (2017)